SLC6A1 and epilepsy with myoclonic atonic seizures: Subsequently, A study describing pathogenic SLC6A1 variants in patients with myoclonic atonic epilepsy (MAE) and intellectual disability (ID) found that 16 of 34 probands with SLC6A1 pathogenic variation collected were consistent with MAE diagnostic criteria.